Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sage Menogen tablets seized; firm settles with Estratest manufacturer Solvay.

Executive Summary

SAGE MENOGEN ESTERIFIED ESTROGENS/METHYLTESTOSTERONE GENERIC TABLETS SEIZED Jan. 9, following a Jan. 5 request for seizure of two lots (approximately 1,061 bottles) of Menogen by Florida U.S. Attorney Thomas Scott. The request for seizure states that the product had been shipped in interstate commerce although "no approvals of applications filed [with FDA] are in effect for such drugs." In addition, as part of a Dec. 8 settlement with Solvay Pharmaceuticals, Sage is enjoined from further manufacturing or marketing of Menogen. Solvay markets Estratest (esterified estrogens and methyltestosterone).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS031690

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel